Value Exchange International, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
OTC.Pink
Robert Trapp has resigned as a non-executive director and Audit Committee member of Value Exchange International, effective November 9, 2025, with no reported disagreements.
OTC.Pink
8-K: Value Exchange International's Auditor Resigns Over Unpaid Fees, Company Faces Delinquent Filings
Value Exchange International, Inc. announced its independent auditor, Grassi & Co. CPAs P.C., disengaged due to outstanding fees, leading to delays in critical financial report filings.
OTC.Pink
Value Exchange International, Inc. has been moved from the OTCQB marketplace to the less transparent OTC Pink Limited Information marketplace due to its failure to timely file its annual Form 10-K report for the year ended December 31, 2024.
OTC.Pink
8-K: Value Exchange International Regains OTC QB Venture Market Listing After Filing Delinquent Reports
Value Exchange International's common stock has been relisted on the OTC QB Venture Market after the company filed its overdue annual and quarterly reports.
OTC.Pink
Value Exchange International's board has clarified the independence status of its directors following a review prompted by a loan agreement with Hapi Metaverse, Inc.
OTC.Pink
8-K/A: Value Exchange International Amends 8-K Filing to Clarify Director Independence and Affiliations
Value Exchange International has filed an amendment to its previous 8-K report to clarify the independence of certain directors and their affiliations following a board review.
OTC.Pink
Value Exchange International, Inc. has entered into a lease agreement for new principal executive offices in Hong Kong, commencing February 1, 2024.